Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

被引:20
|
作者
Hoelzer, S
Steiner, D
Bauer, R
Reiners, C
Farahati, J
Hundahl, SA
Dudeck, J
机构
[1] Univ Giessen, Inst Med Informat, D-35392 Giessen, Germany
[2] Univ Giessen, Clin Nucl Med, D-35392 Giessen, Germany
[3] Univ Wurzburg, Clin & Policlin Nucl Med, D-97070 Wurzburg, Germany
[4] Amer Coll Surg, Commiss Canc, Chicago, IL USA
关键词
differentiated thyroid cancer; guidelines; radioiodine; treatment;
D O I
10.1007/s002590000333
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996, The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.
引用
收藏
页码:1465 / 1472
页数:8
相关论文
共 50 条
  • [1] Radioiodine in differentiated thyroid cancer
    Borner, AR
    MullerGartner, HW
    ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (04): : 274 - 285
  • [2] Differentiated Thyroid Cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine Treatment
    Chiapponi, Costanza
    Hartmann, Milan Janis Michael
    Decarolis, Boris
    Simon, Thorsten
    Bruns, Christiane Josephine
    Faust, Michael
    Schultheis, Anne Maria
    Schmidt, Matthias
    Alakus, Hakan
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2023, 15 (03) : 257 - 263
  • [3] Differentiated Thyroid Cancer: How Do Current Practice Guidelines Affect Management?
    Owens, Patrick W.
    McVeigh, Terri P.
    Fahey, Eoin J.
    Bell, Marcia
    Quill, Denis S.
    Kerin, Michael J.
    Lowery, Aoife J.
    EUROPEAN THYROID JOURNAL, 2018, 7 (06) : 319 - 326
  • [4] Current issues in the management of differentiated thyroid cancer
    Mallick, UK
    Charalambous, H
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (09) : 873 - 881
  • [5] Treatment strategy by radioiodine refractory differentiated thyroid cancer
    Mantsopoulos, Konstantinos
    Mueller, Sarina K.
    Pavel, Marianne
    Kuwert, Torsten
    Meidenbauer, Norbert
    Fietkau, Rainer
    Sievert, Matti
    Iro, Heinrich
    LARYNGO-RHINO-OTOLOGIE, 2022, 101 (04) : 298 - 303
  • [6] Indications and results of radioiodine treatment of differentiated thyroid cancer
    Riemann, B.
    CHIRURG, 2020, 91 (12): : 1013 - 1016
  • [7] Confronting the practice of surgery on differentiated thyroid cancer with current guidelines in Germany - A multicenter trial
    Schwab, R
    Wieler, H
    Birtel, S
    Ostwold-Lenz, E
    Kaiser, KP
    Becker, HP
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (05): : 185 - 191
  • [8] Current practice in intermediate risk differentiated thyroid cancer - a review
    Padovani, Rosalia do Prado
    Duarte, Fernanda Barbosa
    Nascimento, Camila
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (01) : 95 - 108
  • [9] Recurrent Differentiated Thyroid Cancer: The Current Treatment Options
    Coca-Pelaz, Andres
    Rodrigo, Juan Pablo
    Shah, Jatin P.
    Nixon, Iain J.
    Hartl, Dana M.
    Robbins, K. Thomas
    Kowalski, Luiz P.
    Makitie, Antti A.
    Hamoir, Marc
    Lopez, Fernando
    Saba, Nabil F.
    Nuyts, Sandra
    Rinaldo, Alessandra
    Ferlito, Alfio
    CANCERS, 2023, 15 (10)
  • [10] False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
    Barbaro, Daniele
    Campenni, Alfredo
    Forleo, Raffaella
    Lapi, Paola
    ENDOCRINE, 2023, 81 (01) : 30 - 35